|
Martinez-Alcaraz M, Gil M, Llorente S, Botella C, Galian JA, Gonzalez-Lopez R, Fernandez-Gonzalez M, Alegria MJ, Hita A, Moya MR, Martinez-Banaclocha H, Muro-Perez M, Muro J, Minguela A, Legaz I, Muro M. Evaluation of desensitizing therapies for donor-specific antibodies in confirmed humoral allograft rejection in kidney transplantation: Experience of a center for 10 years. Transpl Immunol. 2026 Feb 13:102363. doi: 10.1016/j.trim.2026.102363. Online ahead of print. PubMed PMID: 41692073.
AÑO: 2026; IF: 1.4
|
41692073
|
Alfaro R, Gonzalez-Martinez G, Muro-Perez M, Galian JA, Martinez-Banaclocha H, Fernandez-Gonzalez M, Botella C, Moya-Quiles MR, Muro J, Llorente S, Muro M. Advanced in silico drug design strategies for mitigating transplant rejection: a status update. Expert Opin Drug Discov. 2026 Mar 10. doi: 10.1080/17460441.2026.2642965. Online ahead of print. PubMed PMID: 41804282.
AÑO: 2026; IF: 4.9
|
|
Fernandez-Gonzalez M, Llorente S, Botella C, Galian JA, Gonzalez-Lopez R, Alegria-Marcos MJ, Hita A, Moya-Quiles R, Martinez-Banaclocha H, Muro-Perez M, Muro J, Minguela A, Legaz I, Muro M. Donor-Derived Cell-Free DNA in Allograft Transplantation: Exaggerated Hope or Cautious Reality? Biomedicines. 2025 Sep 23;13(10):2325. doi: 10.3390/biomedicines13102325. PubMed PMID: 41153612; PubMed Central PMCID: PMC12561215.
AÑO: 2025; IF: 3.9
|
|
Fernandez-Gonzalez M, Llorente S, Galian JA, Botella C, Gonzalez-Lopez R, Alegria MJ, Hita A, Moya-Quiles MR, Martinez-Banaclocha H, Muro-Perez M, Muro J, Minguela A, Legaz I, Muro M. Influence and Role of Regulatory B Cells in Organ Transplantation: The State of the Art, Prospects, and Emerging Insights. Antibodies (Basel). 2025 Nov 7;14(4):95. doi: 10.3390/antib14040095. PubMed PMID: 41283510; PubMed Central PMCID: PMC12641717.
AÑO: 2025; IF: 2.7
|
|
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Martinez Banaclocha H, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia. Clin Transl Oncol. 2024 Jan;26(1):278-287. doi: 10.1007/s12094-023-03251-0. Epub 2023 Jun 27. PubMed PMID: 37368200.
AÑO: 2024; IF: 2.5
|